No association of the common Asian mitochondrial DNA haplogroups with lung cancer in East Indian population

Author:

Saha Tania1,Bhowmick Bismoy1,Sengupta Debmalya1,Banerjee Souradeep1,Mitra Ritabrata2,Sarkar Abhijit3,Chaudhuri Tamohan3,Bhattacharjee Gautam3,Nath Somsubhra4,Roychoudhury Susanta5,Sengupta Mainak1

Affiliation:

1. Department of Genetics , University of Calcutta , Kolkata , West Bengal , India

2. Department of Pulmonary medicine (Chest) , IPGMER , Kolkata , West Bengal , India

3. Department of Radiotherapy , SGCCRI , Kolkata , West Bengal , India

4. Molecular Biology and Basic Research Division, SGCCRI , Kolkata , West Bengal , India

5. CSIR-Indian Institute of Chemical Biology , Kolkata , West Bengal , India

Abstract

Abstract Objectives Mitochondrial dysfunction has long been associated with the pathogenesis of lung cancer (LC). Mitochondrial DNA (mtDNA) haplogroups have been reported to modify the risk of LC in a few different populations; however, no study has been done among the Indians. Here, we explore the relationship between mtDNA haplogroups and LC in a representative eastern Indian sample set. Methods Different combinations of six mtDNA SNPs, which define the major Asian mtDNA haplogroups M and N, and their sub-haplogroups D, G, M7, R, and F were genotyped via polymerase chain reaction (PCR) – restriction fragment length polymorphism (RFLP) – sequencing approach in 94 smoker LC patients and 100 healthy smoker controls from an eastern Indian cohort. Results The distribution of 7 mtDNA haplogroups did not show any significant differences between patients and controls (p<0.05). We did not find sub-haplogroup M7 in our study population. Conclusions Our study is the first to indicate that the major Asian mtDNA haplogroups have no significant (p<0.05) association with LC in East Indian population.

Publisher

Walter de Gruyter GmbH

Subject

Drug Discovery,Pharmacology,General Medicine,Physiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3